Thomas Malcolm
Fondateur chez CaraVan Biologix, Inc.
Profil
Thomas Malcolm is the founder of Excision BioTherapeutics, Inc. (founded in 2015) where he held the title of President, Chief Executive Officer & Director.
He is also the founder of CaraVan Biologix, Inc. (founded in 2020) where he currently holds the title of President, Director & Chief Scientific Officer.
Additionally, Dr. Malcolm is the founder of Kermode Biotechnologies, Inc. (founded in 2019) where he currently holds the title of Chief Operating Officer, CSO & Director.
Postes actifs de Thomas Malcolm
| Sociétés | Poste | Début |
|---|---|---|
CaraVan Biologix, Inc.
 CaraVan Biologix, Inc. Medical/Nursing ServicesHealth Services CaraVan Biologix, Inc. provides healthcare services. The private company is based in Andover, NJ. The company was founded by Thomas Malcolm. Jeffrey Riley has been the CEO of the company since 2021. | Fondateur | 01/05/2020 |
| Kermode Biotechnologies, Inc. | Fondateur | 01/01/2019 |
Anciens postes connus de Thomas Malcolm
| Sociétés | Poste | Fin |
|---|---|---|
Excision BioTherapeutics, Inc.
 Excision BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Excision BioTherapeutics, Inc. develops gene editing therapeutics for the treatment of life-threatening disease caused by viral infections. The firm focuses on Human Immunodeficiency Virus -1 therapeutics, JC Virus and Progressive Multifocal Leukoencephalopathy, Hepatitis B virus therapeutics, and CRISPR vaccinations?. The company was founded by David Rowe, Kamel Khalili, Thomas Malcolm, and Rob Simmons in 2015 and is headquartered in San Francisco, CA. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Excision BioTherapeutics, Inc.
Excision BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Excision BioTherapeutics, Inc. develops gene editing therapeutics for the treatment of life-threatening disease caused by viral infections. The firm focuses on Human Immunodeficiency Virus -1 therapeutics, JC Virus and Progressive Multifocal Leukoencephalopathy, Hepatitis B virus therapeutics, and CRISPR vaccinations?. The company was founded by David Rowe, Kamel Khalili, Thomas Malcolm, and Rob Simmons in 2015 and is headquartered in San Francisco, CA. | Commercial Services |
CaraVan Biologix, Inc.
CaraVan Biologix, Inc. Medical/Nursing ServicesHealth Services CaraVan Biologix, Inc. provides healthcare services. The private company is based in Andover, NJ. The company was founded by Thomas Malcolm. Jeffrey Riley has been the CEO of the company since 2021. | Health Services |
| Kermode Biotechnologies, Inc. |
